Medigate

Overview

Medigate is a cybersecurity platform focused on protecting medical devices and other connected health products within healthcare facilities. The company was founded in 2017 by Jonathan Langer, Itay Kirshenbaum, and Pini Pinhasov. Based in New York, USA, and Tel Aviv, Israel, Medigate specializes in healthcare IoT security, providing solutions for threat detection, attack prevention, and device management. The company has raised a total of $50.3 million from investors, including USVP and Blumberg Capital. In 2021, Medigate was acquired by Claroty, expanding its reach and capabilities in the cybersecurity field.

Recent Developments

July 2025: Medigate by Claroty won the Best in KLAS Award for Healthcare IoT Security for the fifth consecutive year, recognized for its innovation and effectiveness in protecting healthcare infrastructures.
June 2025: Medigate strengthened its partnerships with key players in the healthcare industry, enhancing cybersecurity solutions in collaboration with companies like Siemens Healthineers.
April 2025: Claroty, the parent company of Medigate, secured over $400 million in funding to further develop cybersecurity solutions focused on smart, connected devices across industrial and healthcare sectors.
December 2024: The NHS Digital in the UK introduced new guidelines requiring network segregation and microsegmentation, effectively expanding the requirements for Medigate’s services within the healthcare sector.
July 2024: Medigate continued to expand its presence globally, collaborating with European healthcare systems to enhance their cybersecurity frameworks.

Attribute	Information
Founding Date	2017
Headquarters	New York, USA / Tel Aviv, Israel
Founders	Jonathan Langer, Itay Kirshenbaum, Pini Pinhasov
Revenue	$9.1M in 2024
Key Investors	USVP, Blumberg Capital, YL Ventures
Industry	Cybersecurity, Healthcare IoT
Number of Employees	130

Early History

Medigate was founded in 2017 by cybersecurity experts Jonathan Langer, Itay Kirshenbaum, and Pini Pinhasov. Understanding the growing interconnection of medical devices and the associated cybersecurity risks, the founders focused their efforts on healthcare IoT security. Medigate quickly attracted venture capital and strategic partnerships due to its unique platform, which provides comprehensive visibility and threat detection solutions tailored specifically for medical environments. Within a short span, Medigate's offerings gained traction, leading to early-market expansion and setting the stage for the company's rapid growth.

Company Profile and Achievements

Medigate has developed a robust cybersecurity platform explicitly designed for healthcare environments, focusing on the security of connected medical devices and IoT systems. Key aspects include:

Comprehensive Security: Utilizing deep packet inspection, the platform detects and identifies devices on a network, analyzing traffic to prevent malicious activities.
Partnerships and Collaborations: Collaborated with cybersecurity entities such as Check Point and healthcare giants like Siemens Healthineers to improve medical device security.
Multiple Industry Awards: Recognized multiple times for innovation, Medigate has received numerous awards, including Best in KLAS for Healthcare IoT Security.
Strategic Acquisitions: Acquired by Claroty in 2021, this partnership enabled a broader scope of protection across both healthcare and industrial sectors.
Global Expansion: Continuous extension of their services internationally, providing enhanced security solutions to healthcare systems worldwide.

Current Operations and Market Position

Currently operating under Claroty, Medigate remains a leader in the domain of medical device security. The company has leveraged advanced technologies to deliver cybersecurity solutions to over 2,000 hospitals globally, showcasing significant market penetration.

Market Share: Maintains a robust market position with cutting-edge solutions in IoT security, setting benchmarks in healthcare cybersecurity.
Competitive Edge: Delivers unparalleled clinically-driven security solutions, ensuring patient safety through innovative cybersecurity technologies.
Strategic Initiatives: Focused on integrating AI and IoT data insights, enhancing healthcare systems' capabilities to manage and secure device networks.

Conclusion

As an innovator in the healthcare cybersecurity field, Medigate has steadily grown by offering specialized security solutions, effectively responding to the escalating cybersecurity demands within healthcare facilities. The acquisition by Claroty has enhanced Medigate’s capabilities, broadening its service scope across converging healthcare and industrial markets. Looking forward, Medigate continues to spearhead initiatives for improved health cybersecurity, aligning with global developments and compliance requirements, securing its reputation as an industry leader.